Most physicians said the positives of clozapine's REMS outweighed its negatives. Most also said that mandatory blood testing was necessary, but it created a burden and medication delays. In 2024, an ...
An inter-departmental research team has conducted an analytic real-world cohort study on the association of clozapine, a highly efficacious antipsychotic drug, with the incidence of blood cancer.
Federal regulators will no longer require patients to provide blood tests before receiving the drug from pharmacies. By Ellen Barry The Food and Drug Administration has taken a crucial step toward ...
FRIDAY, Feb. 28, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has removed one hurdle faced by patients with schizophrenia when filling prescriptions for the antipsychotic medication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback